Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Dec 29, 2021--
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to virtually participate in the 40 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 5:15 p.m. ET.
A live and archived webcast for this event will be available in the Investors section of the Glaukos website at http://investors.glaukos.com.
Glaukos ( www.glaukos.com ) is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. Glaukos launched the iStent ®, its first MIGS device, in the United States in 2012, its next-generation iStent inject® device in the United States in 2018 and most recently, its iStent injectW device in the United States in 2020. In corneal health, Glaukos’ proprietary suite of single-use, bio-activated pharmaceuticals are designed to strengthen, stabilize and reshape the cornea through a process called corneal collagen cross-linking to treat corneal ectatic disorders and correct refractive conditions. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies in glaucoma, corneal health and retinal disease.
View source version on businesswire.com:https://www.businesswire.com/news/home/20211229005055/en/
CONTACT: Chris Lewis
Sr. Director, Investor Relations & Corporate Strategy & Development
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: SURGERY MEDICAL DEVICES HEALTH PHARMACEUTICAL OPTICAL
SOURCE: Glaukos Corporation
Copyright Business Wire 2021.
PUB: 12/29/2021 07:00 AM/DISC: 12/29/2021 07:02 AM